APA (7th ed.) Citation

Curry, N., Davenport, R., Lucas, J., Deary, A., Benger, J., Edwards, A., . . . Stanworth, S. J. (2023). The CRYOSTAT2 trial: The rationale and study protocol for a multi‐Centre, randomised, controlled trial evaluating the effects of early high‐dose cryoprecipitate in adult patients with major trauma haemorrhage requiring major haemorrhage protocol activation. Transfusion Medicine, 33(2), 123. https://doi.org/10.1111/tme.12932

Chicago Style (17th ed.) Citation

Curry, Nicola, et al. "The CRYOSTAT2 Trial: The Rationale and Study Protocol for a Multi‐Centre, Randomised, Controlled Trial Evaluating the Effects of Early High‐dose Cryoprecipitate in Adult Patients with Major Trauma Haemorrhage Requiring Major Haemorrhage Protocol Activation." Transfusion Medicine 33, no. 2 (2023): 123. https://doi.org/10.1111/tme.12932.

MLA (9th ed.) Citation

Curry, Nicola, et al. "The CRYOSTAT2 Trial: The Rationale and Study Protocol for a Multi‐Centre, Randomised, Controlled Trial Evaluating the Effects of Early High‐dose Cryoprecipitate in Adult Patients with Major Trauma Haemorrhage Requiring Major Haemorrhage Protocol Activation." Transfusion Medicine, vol. 33, no. 2, 2023, p. 123, https://doi.org/10.1111/tme.12932.